Company profile: BioCentriq
1.1 - Company Overview
Company description
- Provider of cell and gene therapy development and GMP manufacturing services, including process development (upstream and downstream), clinical-grade drug product manufacturing across all trial phases, MS&T technical and regulatory support, quality assurance for cGMP compliance, workforce development training, and the LEAP Advanced Therapy Platform to accelerate transition from contract to clinic.
Products and services
- GMP Manufacturing: cGMP-compliant production of clinical-grade drug products and substances for cell therapy, supporting all phases of clinical trials
- Process Development: custom-engineered optimization and scaling of cell and gene therapies for clinical manufacturing, including both upstream and downstream processing
- LEAP Advanced Therapy Platform: modular platform that accelerates development of cell therapy products, enabling faster transition from contract to clinic
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BioCentriq
Adams Clinical
HQ: United States
Website
- Description: Provider of late-phase psychiatric and neurologic clinical trials in Massachusetts, conducting double-blind, randomized, placebo-controlled studies on investigational drugs. Also runs open-label depression monitoring (TRAIT-MDD-107) and Alzheimer's studies: ABBV-552 (M23-515 AbroAD) for mild AD and remternetug (J1G-MC-LAKC TRAILRUNNER-ALZ-1) for early symptomatic AD.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adams Clinical company profile →
Lexitas
HQ: United States
Website
- Description: Provider of full-service ophthalmology CRO solutions for pharma and biotech, including end-to-end clinical operations, global site relationships and international regulatory expertise, medical and regulatory writing, medical monitoring, reading center image assessments, and data management, biostatistics, and statistical programming.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lexitas company profile →
StatFinn
HQ: Finland
Website
- Description: Provider of clinical trial biostatistics and data management, statistical, consulting, and CoPE services in the health sector.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full StatFinn company profile →
Phlow
HQ: United States
Website
- Description: Provider of affordable, quality essential medicines using U.S.-based advanced manufacturing processes. Helps ensure the quality, safety, and affordability of pharmaceutical products of strategic importance to the United States, leveraging advanced manufacturing platforms, including continuous manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phlow company profile →
PPD
HQ: United States
Website
- Description: Provider of CRO services across multiple therapeutic areas, enabling accelerated innovation and drug development through patient-centered strategies and data analytics. Offerings include GMP laboratory and analytical services, Decentralized Clinical Trials, Accelerated Enrollment Solutions, Preclarus data integration tools, regulatory affairs services, and integrated clinical development consulting.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PPD company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BioCentriq
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BioCentriq
2.2 - Growth funds investing in similar companies to BioCentriq
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BioCentriq
4.2 - Public trading comparable groups for BioCentriq
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →